Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan

Autor: Takeshi Matsumura, Kazuyoshi Kon, Etsuko Hashimoto, Hiroshi Inoue, Eiichi Araki, Hitoshi Shimano, Kosuke Kashiwabara, Naoto Kubota, Kazuhiko Koike, Ryosuke Tateishi, Yutaka Matsuyama, Hirotaka Watada, Takeshi Okanoue, Goshi Shiota, Hideo Tanaka, Sumio Watanabe, Kohjiro Ueki, Masato Kasuga, Lucid study investigators, Takumi Kawaguchi, Naoto Fujiwara, Shuichi Kaneko, Toshihide Shima, Takayoshi Sasako, Koji Uchino, Makiko Taniai, Takafumi Senokuchi
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Journal of Gastroenterology
ISSN: 1435-5922
0944-1174
Popis: Background Although type 2 diabetes mellitus (T2DM) is a known risk factor for hepatocellular carcinoma (HCC) development, the annual incidence in diabetes patients is far below the threshold of efficient surveillance. This study aimed to elucidate the risk factors for HCC in diabetic patients and to determine the best criteria to identify surveillance candidates. Methods The study included 239 patients with T2DM who were diagnosed with non-viral HCC between 2010 and 2015, with ≥ 5 years of follow-up at diabetes clinics of 81 teaching hospitals in Japan before HCC diagnosis, and 3277 non-HCC T2DM patients from a prospective cohort study, as controls. Clinical data at the time of and 5 years before HCC diagnosis were collected. Results The mean patient age at HCC diagnosis was approximately 73 years, and 80% of the patients were male. The proportion of patients with insulin use increased, whereas the body mass index (BMI), proportion of patients with fatty liver, fasting glucose levels, and hemoglobin A1c (HbA1c) levels decreased significantly in 5 years. In the cohort study, 18 patients developed HCC during the mean follow-up period of 4.7 years with an annual incidence of 0.11%. Multivariate logistic regression analyses showed that the FIB-4 index was an outstanding predictor of HCC development along with male sex, presence of hypertension, lower HbA1c and albumin levels, and higher BMI and gamma-glutamyl transpeptidase levels. Receiver-operating characteristic analyses showed that a FIB-4 cut-off value of 3.61 could help identify high-risk patients, with a corresponding annual HCC incidence rate of 1.1%. Conclusion A simple calculation of the FIB-4 index in diabetes clinics can be the first step toward surveillance of HCC with a non-viral etiology.
Databáze: OpenAIRE
Externí odkaz: